Radiographic progression during the first 6 months of disease in recent-onset rheumatoid arthritis (RA): the premier study of Adalimumab (HumiraC) therapy in early RA

Abstract

Radiographic progression during the first 6 months of disease in recent-onset rheumatoid arthritis (RA): the premier study of Adalimumab (HumiraC) therapy in early RA